antiangiogenic - Robuta Search

https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2025-06974&r=1 Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and... Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined with Immunotherapy (Pembrolizumab) for pMMR,... https://www.mdpi.com/1424-8247/7/4/464 In Vivo Monitoring of the Antiangiogenic Effect of Neurotensin Receptor-Mediated Radiotherapy by... The neurotensin receptor (NTS1) has emerged as an interesting target for molecular imaging and radiotherapy of NTS-positive tumors due to the overexpression in... in vivo of the https://pmc.ncbi.nlm.nih.gov/articles/PMC39899/ Antiangiogenic therapy of transgenic mice impairs de novo tumor growth - PMC Angiogenesis is activated during multistage tumorigenesis prior to the emergence of solid tumors. Using a transgenic mouse model, we have tested the... antiangiogenic therapy transgenic mice de novo https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2025-06974 Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and... Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined with Immunotherapy (Pembrolizumab) for pMMR,... https://pmc.ncbi.nlm.nih.gov/articles/PMC21162/ Antiangiogenic gene therapy targeting the endothelium-specific receptor tyrosine kinase Tie2 - PMC Angiogenesis is required for tumor growth and metastasis, and inhibition of angiogenesis is a promising approach for anticancer therapy. Tie2 (a.k.a Tek) is an... receptor tyrosine kinase gene therapy https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2025.1518217/full Frontiers | Neoadjuvant chemotherapy combined with antiangiogenic therapy and immune checkpoint... BackgroundAlthough immune checkpoint inhibitors (ICIs) and anti-angiogenic drugs have demonstrated effectiveness in treating advanced gastric cancer (GC), th... neoadjuvant chemotherapy frontiers combined antiangiogenic immune https://www.jci.org/articles/view/70212 JCI - Recent molecular discoveries in angiogenesis and antiangiogenic therapies in cancer jci recent molecular discoveries angiogenesis https://www.frontiersin.org/journals/neurology/articles/10.3389/fneur.2018.00051/full Frontiers | Commentary: Pitfalls in the Neuroimaging of Glioblastoma in the Era of Antiangiogenic... The profoundly aggressive nature of glioblastoma (GBM) leads to a dismal prognosis, with an overall survival of 15 months with standard surgery and chemoradi... in the frontiers commentary pitfalls neuroimaging